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The scope of mental health research
during the COVID-19 pandemic and
its aftermath
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Summary
The effects of the COVID-19 pandemic on population mental
health are unknown. We need to understand the scale of any
such impact in different sections of the population, who is most
affected and how best to mitigate, prevent and treat any excess
morbidity. We propose a coordinated and interdisciplinary
mental health science response.
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It is self-evident that the COVID-19 pandemic has profound conse-
quences for individuals and societies. Most research has under-
standably been focused on understanding the dynamics of the
pandemic and the biology of the infection in order to develop diag-
nostics, vaccines and treatments. However, we know that, with time,
the current spike of infections will pass. There will be headline mor-
tality figures and infection rates, lessons learned about emergency
preparedness, debates about the merits of competing strategies to
control the infection, but as the rate of new infections continues
to slow, schools will reopen and some semblance of normality will
return. However, the impact of the pandemic on human health is
likely to be felt for much longer than the first wave of severe
illness and death.
The long-term effects of the virus
Neurological and psychiatric consequences
The long-term effects of SARS-CoV-2, the virus that causes
COVID-19, on those who recover from the acute respiratory
phase of COVID-19 are unknown. Just over one-third of patients
with COVID-19 in Wuhan had neurological symptoms noted in
their case notes, with anosmia and ageusia recognised as early symp-
toms unrelated to mucosal congestion.1 Other coronaviruses are
neurotropic and capable of infecting neurons trans-synaptically.
The immune response to infection could also have adverse effects
on brain function. It is possible that infection or inflammation of
homeostatic centres of respiration in the brain-stemmay contribute
to respiratory distress or failure. In the longer term, Parkinsonian
symptoms were an important late complication of the 1918–1919
influenza pandemic, and neuropsychiatric complications may simi-
larly arise following SARS-CoV-2 infection. As yet, virtually nothing
is known of the neuropathology of the infection. However, even
without direct effects on the brain, long-term mental health conse-
quences might be anticipated. Mental disorders and cognitive impair-
ments are common following treatment in intensive care. The
systemic effects of infection, including cytokine storms as part of
intense inflammatory or autoimmune response, combined with the
mortal threat of the illness, constitute major biological and psycho-
logical stresses. It is plausible that there may be post-traumatic
stress reactions, persistent fatigue, depression or physical symptoms
of unclear aetiology as a chronic consequence of this acute combin-
ation of infection, health anxiety and heightened stress.
Psychosocial impacts
However, for all of us – not just those infected or seriously ill – the psy-
chosocial impacts of the pandemic are profound. The closure of
schools, nurseries, pubs, shops, gyms and workplaces; the effect of
self-isolation and loneliness, particularly for older people and those
with multiple morbidities; the potential of self-isolation to exacerbate
adverse home environments for children as well as adults, including
domestic violence and abuse; the loss of employment, particularly
for those with the most precarious working lives; the misinformation,
confusion and, for some, anger around government policy; and the
unprecedented restrictions on liberty resulting from public health
measures to stem the pandemic affect every part of society, although
those already disadvantaged will be most affected. We have already
seen evidence of the pandemic having particularly adverse outcomes
for people from Black and minority ethnic groups – these differential
effects on mental and physical health need to be better understood.
The longer-term impacts of a likely recession may ultimately have a
more significant effect on health – particularly mental health – than
the crisis itself. It is unknown whether or how these changes in our
lives will affect mental health, and therefore research to monitor
self-harm and suicide and the prevalence of mental and substance
use disorders in the general population and populations at particular
risk is vital.2
People with mental disorders may be particularly susceptible to
these wider societal impacts. The anxieties associated with the
The British Journal of Psychiatry (2020)
Page 1 of 3. doi: 10.1192/bjp.2020.125
1
Downloaded from https://www.cambridge.org/core. 31 Aug 2020 at 11:12:53, subject to the Cambridge Core terms of use.
pandemic may be more salient to people with pre-existing disorders
– for example those with obsessive–compulsive disorders may be
particularly affected by advice to hand-wash, or those with psych-
otic disorders may be more prone to subsume COVID-related
threat preoccupations into delusional systems. There are significant
challenges in deliveringmental healthcare, particularly to those with
the most severe difficulties, with the pandemic affecting already
depleted staffing complements. Much routine mental healthcare
has suddenly been curtailed or is now delivered remotely via
video conferencing. What impact this has on the quality of patients’
care is unknown.
Meanwhile for the health and social care workforce, from the
front-line staff in acute medicine and intensive care units to those
helping frail elderly care-home residents, there are well-publicised
challenges in terms of high job demands, lack of personal protective
equipment, an atmosphere of heightened threat and potential
‘moral injury’ – the psychological impact of being forced to make
hard choices that jar against the individual’s ethical norms.3
Questions for mental health research
A group convened by the mental health research charity MQ and
the Academy of Medical Sciences has now developed a series of
recommendations, published in The Lancet Psychiatry,4 to prioritise
the research agenda for mental health science in the COVID-19
pandemic. The work of the group was informed by a rapid public
consultation and collaboration with experts with lived experience
and other research consumers, including senior clinicians.
Our single most important message is the need for high-quality
mental health research as part of the wider research response to the
pandemic. Nowhere is the case for integrating mental and physical
health more pressing than in our response to the pandemic. There is
a relatively short window of time in which to act. Existing infra-
structure, data assets and expertise need to be mobilised, with
funding put in place to respond. There are effectively three types
of questions to answer, discussed in the paragraphs below, which
apply to virtually every group affected by the pandemic. Who is
most affected? Why and how are they affected? And what can be
done to prevent, mitigate or treat problems faced by these groups?
Who is most affected?
It is necessary first to understand the impact, if any, of the pandemic
on various mental health outcomes across society. For the general
population has there been an increase in suicide or self-harm,
anxiety or depression? For people with pre-existing mental disor-
ders, has the mortality gap widened as a result of their multiple dis-
advantages? For children and young people, has the prolonged
period of school and university closure and uncertainty about
exams affected their mental health? There is a need for epidemiolo-
gically robust methods – using either administrative data from
health records (or similar systems) or by constructing new
surveys. Although there have been many surveys delivered via
social media, these are self-selecting and are likely to exaggerate
health impacts. For the National Health Service (NHS), employers
have a duty of care to understand the effects of work on their
employees, much as the military does during and after deployment.
Why and how are they affected?
We then need to understand mechanisms to explain why some indi-
viduals are more affected than others and how. That is, to be able to
inform mental health interventions, the types of mechanism we are
most interested in are those that are both causal and modifiable.
These mechanisms will range from molecular and physiological to
psychological and societal.5 In understanding long-term outcomes
for people with severe COVID-19 illness, it will be necessary to
resolve whether any effect on mental health arises from the possible
neurotropic action of the virus, a more general impact of the ‘cyto-
kine storm’ that accompanies severe systemic infection, or the
alarming experience of being mortally ill, as related to post-trau-
matic stress reactions. We need to better understand the psycho-
logical mechanisms that account for changes such as anxiety,
depression, self-harm and suicide more generally in the population.
This understanding will inform the development of new mechanis-
tically based psychological treatments that can be delivered under
pandemic conditions.
What can be done to intervene?
Next, there is a need to know what – if anything – should be done to
intervene, bearing in mind that the current surge of cases of
COVID-19 may be only the first in a series of spikes in incidence,
and research conducted now may usefully inform responses to
future waves of infection. Research can identify not only benefits
of treatments, but also the harms of well-meaning interventions,
for example debriefing following traumatic incidents. It is important
that the pandemic response does not exacerbate existing social and
health inequalities. The need to provide interventions at scale and
remotely means that various modalities of digital intervention will
inevitably dominate. Digital tools can operate on a spectrum from
providing information to being used as a vehicle for delivering psy-
chotherapies. We urge caution though, because only a few of the
thousands of apps already available have a robust evidence base.
It is vital that such tools are robustly evaluated before implementa-
tion.5 Randomisation and evaluation of competing digital systems
could be a condition of any roll out in the NHS. Individual-based
interventions are not the only approach and in many settings the
response may be best conceptualised as a social one. Community-
level interventions and volunteering that focus on altruism are an
increasingly prominent response to the pandemic, which may
have direct mental health benefits. For front-line healthcare
workers structural responses relating to rotas and breaks, getting
sufficient sleep, teamworking and practical support from employers
may be more appropriate than individual-level interventions.
Effective population health messaging – getting people to follow
expert advice to reduce risk of COVID-19 infection – is critical
not just for minimising anxiety that may otherwise contribute to
mental health complications but more generally for boosting adher-
ence to social distancing and other measures intended to slow trans-
mission of the virus.We need to know this urgently to help in face of
future waves of the pandemic.
A coordinated research response
If research is to address the diverse challenges to mental health of
the COVID-19 pandemic, several conditions need to be met.
First, no single discipline will be able to address the problem
alone. We call for mental health science, which we see as a multidis-
ciplinary endeavour, combining psychiatry and psychology, neuro-
science and neurology, social sciences, epidemiology and public
health, and lived experience, to work together in responding to
this crisis. Second, it is critical that there are open, two-way channels
between consumers (patients, public and policy makers) and produ-
cers of mental health research, so that scientists are oriented to the
questions that matter most to the public, and policy-making is prop-
erly informed by the best evidence available. Third, cooperation
within and between sectors – research funders, universities, the
NHS, industry and charities – is critical to the rapid and coherent
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deployment of existing infrastructure for mental health research.
Fourth, definitive and impactful research will require national and
international coordination, to ensure that protocols and computer
code are shared, measures are harmonised, and work is done at
scale, with the principles of open science at heart. Although we
must act urgently, we must also be strategic and joined-up in how
we address this challenge from the outset. Our success in under-
standing and mitigating the biological, psychological and social
impacts of COVID-19 onmental health will require new investment
from research funders and coordinated action from the entire com-
munity of mental health scientists.
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